早期重症合免疫妊娠的结果
Kamaldeep Bains1, Subhas Chandra Saha1, Neelam Aggarwal1
1Department of Obstetrics and Gynaecology, PGIMER, Chandigarh, 160012 India.
Journal of obstetrics and gynaecology of India
|June 30, 2025
概括
对于严重免疫妊娠的早期子宫内输血 (IUT) 可以提高围产期生存率. 在妊娠初期迅速诊断和治疗hydrops fetalis导致更好的结果,与以后的输血相比.
科学领域:
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 新生儿科学 新生儿科学
- 免疫学 免疫学 免疫学
背景情况:
- 严重的Rh合免疫接种对胎儿健康构成风险.
- 宫内输血 (IUT) 是受影响胎儿的关键干预措施.
- IUT的及时性可能会影响围产期结局.
研究的目的:
- 为了评估严重的Rh合免疫接种需要在怀孕26周之前进行早期子宫内输血 (IUT) 的怀孕的产周结局.
- 为了将这些结果与26周后需要IUT的非免疫妊娠的结果进行比较.
- 评估早期干预对胎儿存活率和新生儿健康的影响.
主要方法:
- 预期的观察性比较研究.
- 包括需要IUT的Rh组免疫妇女.
- 早期 (<26周) 和晚期 (≥26周) IUT组之间的比较.
- 在早期输血中使用22G针和肝内通路.
主要成果:
- 在44名患者中,有22名患者需要早期的IUT.
- 总共进行了152次IUT;早期组的平均值为4.5,晚期组的平均值为2.2.
- 早期治疗的水性胎儿的存活率更高 (80%与66%).
- 早期组的带回家婴儿率为86.3%,而后期组为82.6%.
结论:
- 早期的IUT用于严重的合免疫,当使用适当的技术进行时,可以产生与后来的输血相比的结果.
- 早期诊断和治疗hydrops fetalis显著提高胎儿存活率.
- 在怀孕早期进行熟练的干预可以提高非免疫妊娠中产周生存率.
更多相关视频
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
11.5K
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
14.7K
相关概念视频
Development of Immunocompetence
454
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
454
Teratogenicity
2.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
Rh Blood Group
1.9K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.9K
Immunodeficiency Diseases
1.2K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.2K
Transcytosis of IgG
2.9K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.9K
